First Phase 1 Double-Blind, Placebo-Controlled, Randomized Rectal Microbicide Trial Using UC781 Gel with a Novel Index of Ex Vivo Efficacy

• Peter A. Anton ,

  * E-mail: panton@mednet.ucla.edu

  Affiliation Center for HIV Prevention Research, UCLA AIDS Institute, Department of Medicine, David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California, United States of America

  ⨯
• Terry Saunders,

  Affiliation Center for HIV Prevention Research, UCLA AIDS Institute, Department of Medicine, David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California, United States of America

  ⨯
• Julie Elliott,

  Affiliation Center for HIV Prevention Research, UCLA AIDS Institute, Department of Medicine, David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California, United States of America

  ⨯
• Elena Khanukhova,

  Affiliation Center for HIV Prevention Research, UCLA AIDS Institute, Department of Medicine, David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California, United States of America

  ⨯
• Robert Dennis,

  Affiliation Center for HIV Prevention Research, UCLA AIDS Institute, Department of Medicine, David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California, United States of America

  ⨯
• Amy Adler,

  Current address: Translational Science Corp, Los Angeles, California, United States of America

  Affiliation Center for HIV Prevention Research, UCLA AIDS Institute, Department of Medicine, David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California, United States of America

  ⨯
• Galen Cortina,

  Affiliation Center for HIV Prevention Research, UCLA AIDS Institute, Department of Medicine, David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California, United States of America

  ⨯
• Karen Tanner,

  Affiliation Center for HIV Prevention Research, UCLA AIDS Institute, Department of Medicine, David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California, United States of America

  ⨯
• John Boscardin,

  Current address: San Francisco VA Medical Center, San Francisco, California, United States of America

  Affiliation Center for HIV Prevention Research, UCLA AIDS Institute, Department of Medicine, David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California, United States of America

  ⨯
• William G. Cumberland,

  Affiliation Department of Biostatistics, University of California Los Angeles School of Public Health, Los Angeles, California, United States of America

  ⨯
• Ying Zhou,

  Affiliation Department of Biostatistics, University of California Los Angeles School of Public Health, Los Angeles, California, United States of America

  ⨯
• Ana Ventuneac,

  Affiliation Department of Psychiatry, Columbia University, New York, New York, United States of America

  ⨯
• Alex Carballo-Diéguez,

  Affiliation Department of Psychiatry, Columbia University, New York, New York, United States of America

  ⨯
• Lorna Rabe,

  Affiliation Magee-Womens Research Institute, University of Pittsburgh Medical School, Pittsburgh, Pennsylvania, United States of America

  ⨯
• Timothy McCormick,

  Affiliation CONRAD, Arlington, Virginia, United States of America

  ⨯
• Henry Gabelnick,

  Affiliation CONRAD, Arlington, Virginia, United States of America

  ⨯
• Christine Mauck,

  Affiliation CONRAD, Arlington, Virginia, United States of America

  ⨯
•  [ ... ],
• Ian McGowan

  Affiliation Magee-Womens Research Institute, University of Pittsburgh Medical School, Pittsburgh, Pennsylvania, United States of America

  ⨯
• [ view all ]
• [ view less ]